CS logo
small CS logo
Legacy Good Samaritan Hospital and Medical Center

Portland, Oregon, United States
Medical center in Portland, Oregon
1015 NW 22nd Ave, Portland, OR 97210

About Legacy Good Samaritan Hospital and Medical Center


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Legacy Good Samaritan Hospital and Medical Center


During the past decade, Legacy Good Samaritan Hospital and Medical Center conducted 83 clinical trials. In the 10-year time frame, 83 clinical trials started and 93 clinical trials were completed, i.e. on average, 112% percent of trials that started reached the finish line to date. In the past 5 years, 27 clinical trials started and 45 clinical trials were completed. i.e. 166.7% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Legacy Good Samaritan Hospital and Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 63 trials, followed by "SWOG Cancer Research Network" with 49 trials sponsored, "Alliance for Clinical Trials in Oncology" with 22 trials sponsored, "NRG Oncology" with 20 trials sponsored and "Legacy Health System" with 20 trials sponsored. Other sponsors include 49 different institutions and companies that sponsored additional 26 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Legacy Good Samaritan Hospital and Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 121 trials as a collaborator, "NRG Oncology" with 36 trials as a collaborator, "Cancer and Leukemia Group B" with 12 trials as a collaborator, "NCIC Clinical Trials Group" with 9 trials as a collaborator and "SWOG Cancer Research Network" with 7 trials as a collaborator. Other collaborators include 74 different institutions and companies that were collaborators in the rest 59 trials.

Clinical Trials Conditions at Legacy Good Samaritan Hospital and Medical Center


According to Clinical.Site data, the most researched conditions in "Legacy Good Samaritan Hospital and Medical Center" are "Breast Cancer" (24 trials), "Recurrent Breast Carcinoma" (9 trials), "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Lymphoma" (8 trials) and "Fallopian Tube Transitional Cell Carcinoma" (7 trials). Many other conditions were trialed in "Legacy Good Samaritan Hospital and Medical Center" in a lesser frequency.

Clinical Trials Intervention Types at Legacy Good Samaritan Hospital and Medical Center


Most popular intervention types in "Legacy Good Samaritan Hospital and Medical Center" are "Drug" (162 trials), "Other" (104 trials), "Radiation" (60 trials), "Biological" (59 trials) and "Procedure" (46 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (52 trials), "Quality-of-Life Assessment" (43 trials), "Questionnaire Administration" (24 trials), "Paclitaxel" (22 trials) and "Carboplatin" (16 trials). Other intervention names were less common.

Clinical Trials Genders at Legacy Good Samaritan Hospital and Medical Center


The vast majority of trials in "Legacy Good Samaritan Hospital and Medical Center" are 148 trials for "All" genders, 58 trials for "Female" genders and 13 trials for "Male" genders.

Clinical Trials Status at Legacy Good Samaritan Hospital and Medical Center


Currently, there are NaN active trials in "Legacy Good Samaritan Hospital and Medical Center". undefined are not yet recruiting, 25 are recruiting, 70 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 100 completed trials in Legacy Good Samaritan Hospital and Medical Center, 3 suspended trials, and 14 terminated clinical trials to date.
Out of the total trials that were conducted in Legacy Good Samaritan Hospital and Medical Center, 8 "Phase 1" clinical trials were conducted, 79 "Phase 2" clinical trials and 120 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 19 trials that are defined as “Not Applicable".